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Mammalian sGC is a heterodimer composed of a- and
b-subunits (Figure 1) [1]. The C-terminus of each sub-
unit contains a catalytic domain, and the active site is
composed of residues from both subunits. Sequence
analysis shows that each subunit also contains a well-
defined PAS-like domain, and a predicted helical
region. The N-termini of the a- and b-subunits are
homologous to the H-NOX (Heme-Nitric oxide/OXy-
gen) family of proteins. The N-terminus of b-subunit
contains a ferrous heme cofactor that serves a receptor
for NO.
Ferric heme oxidized sGC has low activity, and the
NO complex of the re-reduced heme generates a
desensitized, low-activity state of sGC. The molecular
mechanism for this desensitization involves site speci-
fic S-nitrosation. The conformational changes asso-
ciated with activation are both subtle and complex.
Hydrogen-deuterium exchange mass spectrometry ana-
lysis can be used to probe conformational changes and
protein-protein interactions. This method has been
brought to bear on sGC, illuminating domain interac-
tions within sGC and conformational changes induced
by NO binding.
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Figure 1 Schematic of sGC regulation by NO. In the resting, unliganded state, sGC has a low basal activity. The addition of NO leads initially to a
6-coordinate complex that then forms a highly active 5-coordinate complex. Evidence supports an additional requirement for NO that
accelerates the formation of the 5-coordinate complex and fully activates the enzyme.
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